e Dopamine receptor mechanisms are believed to play a role in the reinforcing effects of cocaine and other drugs of abuse. The lack of receptor-selective agonists has made it difficult to determine the role of the individual dopamine receptors in mediating these reinforcing effects. In this study, rhesus monkeys with a history of intravenous cocaine self-administration were tested for the reinforcing effects of several D 3 -preferring agonists, a D 2 -preferring agonist, and a D 4 agonist. The D 2 -preferring agonist did not maintain responding in any monkeys, and the D 4 agonist was self-administered at low rates, just above those maintained by saline, in one monkey. The D 3 -preferring agonists were self-administered by approximately half of the animals, although at lower rates than cocaine. These results indicate that the apparent limited reinforcing effectiveness of D 2 -like agonists requires activity at D 3 receptors. Previous data from this laboratory and others also suggest that these drugs may not serve as reinforcers directly; the behavior may be maintained by responsecontingent delivery of stimuli previously paired with cocaine. The ability of drug-related stimuli to maintain responding apparently differs among monkeys and other organisms, and may be related to individual differences in drug-taking behavior in humans.
Introduction
Although the importance of dopamine neurotransmission in brain reward pathways has been acknowledged frequently (e.g. Wise and Bozarth, 1985; Ritz and Kuhar, 1993) , the role of each of the five subtypes of dopamine receptors in the reward process remains unclear. The D 2 , D 3 , and D 4 receptors are subtypes of the general category of D 2 -like receptors, whereas the D 1 and D 5 receptors comprise the category of D 1 -like receptors. Although considerable amounts of research have been directed toward the evaluation of the behavioral effects of drugs that act specifically on the D 1 -like versus the D 2 -like receptors, further distinctions have been more difficult because of the structural homology among some of the subtypes of these receptors. Of the D 2 -like receptors, which are the focus of the present study, the D 2 and the D 3 receptors have especially high structural homology. Although D 2 and D 3 receptor ligands with relatively high in-vitro selectivity, such as sumanirole (compound (R)-6 in Heier et al., 1997) and pramipexole (Newman-Tancredi et al., 2002) , have been identified, all available compounds have activity at both receptors and seem to show less effective selectivity in vivo . Researchers have therefore been restricted to evaluating drugs that bind to the D 3 site with somewhat higher affinity than they bind to the D 2 site, and vice versa. These are referred to as D 3 -preferring and D 2 -preferring compounds in the present paper.
Two findings in particular have led to increased interest in D 3 receptors: the discovery that these receptors are expressed primarily in the mesocortical limbic reward pathway (Sokoloff et al., 1990; Lévesque et al., 1992) and the observation that Parkinson's disease patients taking D 3 -preferring agonists such as pramipexole or ropinirole occasionally show compulsive behavior such as excessive gambling, shopping, or sexual behavior (Aiken, 2007) . These findings raised the possibility that this receptor subtype is involved in disrupted reinforcement processes such as those observed in drug addiction. D 3 -preferring agonists have frequently been shown to have properties in experimental animals, including nonhuman primates, that are similar to those of cocaine. For example, a presession treatment with the D 3 -preferring agonists quinelorane and 7-OH-DPAT produced leftward shifts in the cocaine dose-effect curves in rhesus monkeys. In fact, following the administration of these drugs, the highest rates of responding occurred when responding produced only the stimuli previously paired with cocaine (Caine et al., 2000) . In addition, some D 3 -preferring agonists (NPA and quinpirole), like cocaine itself, have been shown to reinstate cocaine-extinguished behavior in squirrel monkeys. Others (PD 128,907 and 7-OH-DPAT) did not have this ability, in part because the extremely variable effects of the drugs prevented statistically significant effects (Khroyan et al., 2000) . In a study in which rhesus monkeys chose between cocaine and food, the substitution of saline for cocaine led to the selection of the food alternative. Presession administration of each of the D 3 -preferring agonists quinelorane, R-(+)-NPA, (+)-PHNO, and PD 128,907 produced decreased selection of the food alternative and increased selection of the saline (previously cocaine) alternative. This was similar to the effects produced by presession administration of cocaine. For each of the D 3 -preferring agonists, however, the cocainelike effect was marked in two of the four monkeys and did not occur in the other two monkeys (Gasior et al., 2004) .
Squirrel monkeys trained to discriminate the interoceptive effects of cocaine versus saline showed a maximum of 73% cocaine-appropriate responses following the administration of PD 128,907 (Achat-Mendes et al., 2010) , and (+)-PHNO, quinpirole, and quinelorane on average also produced considerable, but less than 100%, selection of the cocaineappropriate manipulandum (Spealman et al., 1991) . Interestingly, Spealman et al. (1991) indicated that one of the four monkeys tested did show greater than 90% selection of the cocaine-appropriate lever, suggesting individual differences among the monkeys in the detection of the cocaine-like stimulus effects of some D 3 -preferring agonists.
Other findings also indicated that D 3 -preferring agonists produced complete cocaine-like discriminative stimulus effects in a subset (three of four) of rhesus monkeys and served as reinforcers in monkeys with cocaine-selfadministration histories (Nader and Mach, 1996; Sinnott et al., 1999) . It was clear, however, that monkeys required a cocaine self-administration history to show orderly selfadministration of either quinpirole (Sinnott et al., 1999) or 7-OH-DPAT (Nader and Mach, 1996) .
A history of cocaine use has also been shown to be necessary for quinpirole self-administration in the rat (Collins and Woods, 2007) . A history of use of remifentanil was also effective, although less so than a history of use of cocaine, whereas experience with food or ketamine-maintained responding was ineffective in establishing quinpirole-maintained responding. It should be noted that the amounts of both quinpirole and 7-OH-DPAT that were self-administered in most of these studies were sufficient to produce invivo effects that are mediated by both the D 2 and D 3 receptors .
Much less work has been published on the effects of the D 2 -preferring agonist sumanirole on the behavior of rhesus monkeys. Although a recent report suggests that sumanirole is capable of producing dose-dependent increases in cocaine-appropriate responses in both drug discrimination and reinstatement assays in squirrel monkeys (AchatMendes et al., 2010) , to the best of our knowledge, the ability of sumanirole to serve as a reinforcer in monkeys has not been reported. Similarly, although several D 4 -selective agonists have been synthesized recently (Enguehard-Gueiffier and Gueiffier, 2006) , no studies of D 4 -selective agonists in monkeys have been published.
In the present study, agonists that are currently the most selective at each of the three D 2 -like receptors were evaluated for reinforcing effects in rhesus monkeys with a history of cocaine self-administration (Table 1) . By comparing the levels of self-administration of agonists selective for each of the D 2 -like receptors under conditions that promote self-administration of D 3 -preferring agonists, we aimed to determine which D 2 -like receptors were necessary or sufficient to support self-administration behavior. The monkeys were provided access to 0.01 mg/kg/injection cocaine, saline, or one of several D 2 -like agonists during twice-daily sessions (see Table 2 for compounds, receptor binding affinities, and efficacy data). The selected D 2 -preferring agonist was sumanirole In some cases, detailed cocaine intake data were not retrievable for a portion of days when cocaine was available. These cases are not included in the total cocaine and average daily dose calculations, but are included in the days of access figures. 
Methods

Subjects
Seven male (DA, FI, LU, BO, KE, KO, and OZ) and three female (GI, TP, and MA) rhesus monkeys (Macaca mulatta), with varied experimental histories including drug self-administration, served as subjects. At the start of the experiment, the median age of the subjects was 14 years (range 8-20 years) and the median weight was 9.4 kg (range 7.2-13.9 kg). Subjects were given fresh fruit and other edible treats each day and were fed Purina monkey chow to maintain healthy weights (determined by veterinary staff and somewhat less than free-feeding weights). Water and environmental enrichment toys were continuously available, both in and out of session.
Apparatus
Monkeys were housed in stainless-steel cages (83.3 cm high by 76.2 cm wide by 91.4 cm deep) in visual contact with other monkeys of the same species. Located on one side of the cage was an instrument panel containing two or three depressible levers (Model 121-07, BRS-LVE, Laurel, Maryland, USA), each requiring 10-15 g (0.10-0.15 N) of downward force to operate. The levers were separated by 0.3-cm thick stainless-steel dividers extending 8 cm from the response panel. A stimulus light was positioned above each lever. An injection pump was located behind the cage. Experimental events were controlled by computers in an adjacent room running Med-PC IV (Med-Associates, Georgia, Vermont, USA) software.
Monkeys were implanted with intravenous catheters in an internal jugular, external jugular, femoral, or brachial vein. Catheters were routed out subcutaneously from the back of the monkey and through a flexible stainless-steel tether held in place by a Teflon mesh jacket (Lomir, Quebec, Canada). Catheters were implanted under ketamine (10 mg/kg, intramuscular) and xylazine (2 mg/kg, intramuscular) anesthesia.
Procedure
Sessions were conducted twice daily (06:00 and 12:15 h), 7 days/week. Drugs were delivered according to a simple fixed ratio (FR) 10 schedule of reinforcement with a limit of 60 injections in each session and a timeout period of 30 s between response opportunities. The drugs were available for responding on the right lever and their availability was signaled by a red stimulus light above that lever. Responses on the other lever(s) were recorded but had no scheduled consequences. Ten responses in the presence of the red light resulted in the activation of the injection pump, the red light was turned off, and a green light above the right lever was turned on. A volume of 1 ml of fluid was injected over 5 s. After each injection, there was a timeout of 30 s, during which no lights were illuminated and responses had no scheduled consequences. Sessions ended after 2 h or 60 injections, whichever occurred first.
Cocaine was used as the reference drug, and saline or different doses of the test compounds were substituted for cocaine on a regular basis either in the morning or the afternoon session, no more often than once every fourth session (every other day).
Drugs
All drugs were dissolved in sterile saline and reported doses refer to the salts. Cocaine was obtained from National Institute on Drug Abuse, quinpirole was purchased from Sigma-Aldrich (St Louis, Missouri, USA), and ropinirole was purchased from Helix and Bond (Shanghai, China). Suppliers of the other drugs are indicated in the Acknowledgements section.
Data analysis
Cocaine and saline reference data were taken from sessions just preceding substitutions of each of the dopamine agonists. Data from the last three of these sessions of cocaine and saline were averaged to obtain the reference data for each test compound. 'Self-administration' was operationally defined as responding at levels sufficient to obtain 40 or more injections in a single session, a value that differentiated all saline from all cocaine sessions. The averages of the three sessions of tests with each dose of each test drug are presented in the graphs and form the basis for the statistical tests. One-way repeated-measures analysis of variance and Pearson product-moment correlations were carried out using Prism 5 (GraphPad Inc., La Jolla, California, USA), and Wilcoxon's signed-rank tests were carried out in SPSS 17 (IBM Corporation, Armonk, New York, USA). Response rates were log transformed for statistical comparison so that they approximated a normal distribution more closely.
Results
All subjects received the maximum of 60 injections of 0.01 mg/kg/injection cocaine whenever it was available, such that the number of injections across control sessions when cocaine was available was significantly greater than the number of injections when saline was available (top panels of Figs 1-5; Wilcoxon's signed-rank test, z = -2.80, P < 0.01). The response rates maintained by cocaine varied markedly among subjects (bottom panels of Figs 1-5), but were consistently and significantly higher than the rates maintained by saline (z = -2.80, P < 0.01).
Considerable individual differences were seen in responding maintained by the D 3 -preferring agonists quinpirole (Fig. 1) , pramipexole (Fig. 2) , and ropinirole (Fig. 3) . For each drug, about half the subjects self-administered at DA D 2 -like agonist self-administration Koffarnus et al. 333
least one dose at greater rates than saline (Table 3) , but none of the effects on injections or the response rate were statistically significant at a group level. Half of the 10 monkeys tested self-administered quinpirole above saline levels ( Fig. 1, closed symbols) , and the remaining subjects did not self-administer quinpirole (Fig. 1, open  symbols) . Similarly, with pramipexole, the same two of the seven monkeys that showed a clear pattern of quinpirole self-administration were also responsive to the apparent reinforcing effects of pramipexole (Fig. 2) . Four of the remaining five monkeys did not, whereas one monkey (OZ) appeared to self-administer pramipexole but not quinpirole. Only three monkeys were evaluated using ropinirole. Two of these animals self-administered ropinirole at one or more doses (Fig. 3 ). These monkeys had also self-administered quinpirole and pramipexole. The third monkey, which had not self-administered quinpirole or pramipexole, also did not show an apparent reinforcing effect of ropinirole (Fig. 3) .
Sumanirole was not self-administered on a FR 10 schedule above saline levels at any dose tested by any of the five subjects exposed to this D 2 -preferring agonist (Fig. 4, Table 3 ). Two of these monkeys had selfadministered each of the D 3 -preferring agonists. No significant main effect of sumanirole dose was observed on either response rates or injections. One of five monkeys self-administered ABT-724 (Fig. 5 , Table 3 ). The rates and intake were well below those shown by cocaine for this monkey, but above those shown for saline. As with the other drugs, there was no significant main effect of ABT-724 dose on injections or response rates.
There was a significant correlation between the maximum rate obtained at any dose of quinpirole and the rate of responding for cocaine (r = 0.71, P < 0.025). Although the correlation between the maximum pramipexole rate and cocaine rate was moderately high (r = 0.48, NS), this, along with the analogous correlations with the other drugs, was not statistically significant.
Discussion
In the current set of experiments, none of the D 2 -like agonists, acting with some selectively on the D 2 , D 3 , or D 4 receptors, maintained rates of self-administration Self-administered injections (top) and response rates (bottom) maintained by saline, 0.01 mg/kg/injection cocaine, and quinpirole on a fixed ratio 10 schedule of reinforcement. Symbols represent the individual subject mean data from three or more single-session substitutions on a 0.01 mg/kg/injection cocaine baseline. behavior that approximated those maintained by cocaine. The only D 2 -like agonists that appeared to be selfadministered above saline levels in some subjects were those that bind preferentially to D 3 receptors, although it is important to acknowledge that the amounts of D 3 -preferring agonists that were taken by these monkeys were likely sufficient to bind to the D 2 as well as to the D 3 receptor. It appears that D 3 agonism is necessary for D 2 /D 3 agonists to support self-administration, but the current results cannot distinguish whether D 3 agonist activity in the absence of D 2 agonist activity is sufficient. Nevertheless, these data indicate that of the three D 2 -like receptors, only D 3 -preferring agonists support appreciable self-administration, and that cocaine appears to engender much more robust responding by preventing the uptake of monoamines than do agonists that preferentially activate any of the D 2 -like dopamine receptors.
Interestingly, even though the D 3 -preferring agonists were self-administered more readily than were the D 2 -preferring and the D 4 receptor agonists, they did not serve an apparent reinforcing function in all animals. Only five of 10 monkeys showed levels of quinpirole selfadministration that were above those produced by saline. Furthermore, monkeys that showed high levels of quinpirole intake also showed greater levels of intake of ropinirole and pramipexole than monkeys that showed low levels of quinpirole intake.
The finding that quinpirole, pramipexole, and ropinirole maintained substantial intake in some of the monkeys might be considered as evidence that there are individual differences in sensitivity to the reinforcing effects of D 3 -preferring agonists. There are, however, alternative explanations for these data. All of these animals had ongoing experience with cocaine self-administration, but the duration or the amount of previous access did not appear to correlate with propensity to self-administer the D 3 compounds (Table 1) . As shown by Nader and Mach (1996) in rhesus monkeys and by Collins and Woods (2007) in rats, a history of cocaine self-administration is required for D 3 -preferring agonists to show apparent reinforcing effectiveness. Further studies in rats have indicated that noncontingent administration of quinpirole or pramipexole produced increases in responding if, and only if, the response produced a stimulus previously Self-administered injections (top) and response rates (bottom) maintained by saline, 0.01 mg/kg/injection cocaine, and ropinirole on a fixed ratio 10 schedule of reinforcement. Symbols represent the individual subject mean data from three or more single-session substitutions on a 0.01 mg/kg/injection cocaine baseline. Responses per second Self-administered injections (top) and response rates (bottom) maintained by saline, 0.01 mg/kg/injection cocaine, and sumanirole on a fixed ratio 10 schedule of reinforcement. Symbols represent the individual subject mean data from three or more single-session substitutions on a 0.01 mg/kg/injection cocaine baseline.
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paired with contingent cocaine administration (Collins and Woods, 2009; Collins et al., 2012) . It is therefore possible that quinpirole, ropinirole, and pramipexole were not serving as primary reinforcers in any monkeys in the current study, but rather were serving to enhance the motivational effects of the stimulus conditions that were associated with the administration of cocaine. If this was the case, this enhancement was sufficient to produce relatively high rates of responding in half of the monkeys. Although this explanation cannot be confirmed solely on the basis of the current experiment, it is supported by findings that D 3 -preferring agonists increase responding, followed by cocaine-paired stimuli (Caine et al., 2000; Khroyan et al., 2000) .
Rather than increasing stimulus control exerted by cocainepaired stimuli, an alternative explanation that should be considered is that D 3 -preferring agonists actually decrease stimulus control in general. This could account for the variability in reporting a cocaine-like discriminative stimulus effect following the administration of D 3 -preferring agonists (Spealman et al., 1991; Achat-Mendes et al., 2010) and for the increase in timeout responding and the increase in switching between cocaine-associated and food-associated manipulanda (Gasior et al., 2004) .
The potential relevance of D 3 receptor activation in mediating behavioral aspects of conditional reinforcing stimuli has been suggested previously (Pilla et al., 1999; LeFoll et al., 2005; Beninger and Banasikowski, 2008) . Much of this research focused on the demonstration that D 3 -selective, low-efficacy agonists and antagonists are capable of reducing behavior maintained by cues associated with cocaine. In addition to these effects, work from our laboratory has shown that D 3 -preferring agonists (e.g. quinpirole, pramipexole, ropinirole) are capable of not only maintaining responding in rats with a history of cocaine self-administration (Collins and Woods, 2007) but also inducing dose-dependent increases in responding when these responses resulted in the presentation of cocaine-associated stimuli, effects that are absent when stimuli presentations are omitted (Collins and Woods, 2009; Collins et al., 2012) . It is also known that individual differences exist in approach behavior to stimuli associated with food reinforcers in rats (Flagel et al., 2011) . Some rats are prone to approaching the food reinforcers themselves whereas some rats approach the stimuli associated with these reinforcers. If similar individual differences exist in approach behavior in rhesus monkeys, this could explain why D 3 -preferring agonists increase responding maintained by cocaine-paired stimuli only in some subjects. Perhaps it is only those subjects that preferentially attend to the stimuli associated with cocaine that also show increases in the apparent reinforcing effectiveness of D 3 -preferring agonists. This notion is currently untested, but should be the focus of future experiments.
The finding that direct D 2 receptor agonism with sumanirole does not appear to be sufficient to maintain self-administration behavior in cocaine-experienced monkeys is puzzling, especially as sumanirole was recently found to have discriminative stimulus effects that were much like those of cocaine in squirrel monkeys (AchatMendes et al., 2010) . Other investigators have found that D 2 -like agonists do serve as reinforcers in rhesus monkeys Self-administered injections (top) and response rates (bottom) maintained by saline, 0.01 mg/kg/injection cocaine, and ABT-724 on a fixed ratio 10 schedule of reinforcement. Symbols represent the individual subject mean data from three or more single-session substitutions on a 0.01 mg/kg/injection cocaine baseline. (Woolverton et al., 1984; Woolverton, 1986; Ranaldi et al., 2001; Woolverton and Ranaldi, 2002) , but the contribution of D 3 receptors toward these limited reinforcing effects is not known. The lack of reinforcing effects of sumanirole could be attributed to pharmacokinetic aspects, such as a slow onset of action. However, given its fairly rapid onset of hypothermic effect in rats , this is unlikely. More likely is the possibility that insufficiently large doses of sumanirole were tested in this study. It may be that apparent reinforcing effects require the activation of both D 3 and D 2 receptors, and larger doses of this D 2 -preferring agonist are necessary to produce activity at D 3 sites.
The D 4 agonist ABT-724 was self-administered by just one of five monkeys tested (LU), and at rates only slightly higher than saline in that one monkey. No previous studies have evaluated selective D 4 compounds for reinforcing properties, and relatively little research has examined how D 4 receptors are involved in the reinforcing properties of cocaine and other stimulants. The current result showing little reinforcing effect of ABT-724 is in agreement with studies in mice lacking the D 4 receptor that reported no alteration in responding for food or cocaine (Thanos et al., 2010b) and no systematic change in the ability of methylphenidate, amphetamine, and cocaine to elicit a conditioned place preference (Thanos et al., 2010a) . ABT-724 has lower intrinsic efficacy than dopamine at the D 4 receptor (Brioni et al., 2004) , however, leaving open the possibilities that a lack of reinforcing effectiveness may be because of the partial agonist profile of this drug and that a full agonist might maintain more responding. A slow onset of action might also mitigate against an observation of self-administration of ABT-724, but this drug does not appear to have particularly slow absorption (Marona-Lewicka et al., 2008) . From these data, it does not appear that D 4 receptor activation alone is sufficient to maintain robust selfadministration behavior.
The data presented here could be taken as evidence that action at any one of the D 2 -like receptor subtypes is not responsible for the reinforcing effects of cocaine. This is in disagreement to studies that show that D 2 antagonists are much more able than D 3 antagonists to suppress cocaine self-administration in squirrel monkeys (AchatMendes et al., 2010) . Although this could be a species distinction, it is clear that further work with more selective agonists and antagonists is necessary and may help to clarify this issue, which appears to be quite complex.
These data, along with published information, have several implications with respect to the contribution of dopamine D 2 -like receptors toward the underlying mechanism of the reinforcing effects of cocaine, assuming that these are mediated by dopamine reuptake blockade. It appears, using the most selective D 2 , D 3 , and D 4 receptor agonists available, that D 3 /D 2 activation, possibly in concert, is required to maintain responding. It is important to note, however, that these effects are not observed in all animals, which may represent individual differences among the monkeys with respect to the motivational properties of the stimuli that were paired with cocaine rather than the direct reinforcing effect of the drugs themselves.
